| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/10/2009 | WO2009148958A1 Biomarker for assessing response to chymase treatment |
| 12/10/2009 | WO2009148896A2 Anti-phospho-akt antibodies |
| 12/10/2009 | WO2009148549A2 Novel biosensors for live cell imaging of intracellular proteins |
| 12/10/2009 | WO2009148330A1 Compositions and methods for improving plants |
| 12/10/2009 | WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene |
| 12/10/2009 | WO2009147549A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 12/10/2009 | WO2009147384A2 Peptide |
| 12/10/2009 | WO2009147368A1 Peptides |
| 12/10/2009 | WO2009147201A2 Anti-inflammatory agents |
| 12/10/2009 | WO2009147196A1 Hiv-rev-multimerization inhibiting nanobodies |
| 12/10/2009 | WO2009147180A2 Microbicidal peptides of trichoderma reesei |
| 12/10/2009 | WO2009147060A1 Method for purifying erythropoietin |
| 12/10/2009 | WO2009146902A1 A vaccine for the prevention and therapy of hcv infections |
| 12/10/2009 | WO2009146886A2 Novel antibacterial peptides |
| 12/10/2009 | WO2009146867A1 Pestivirus replicons providing an rna-based viral vector system |
| 12/10/2009 | WO2009146803A1 Fully synthetic albumin analogue |
| 12/10/2009 | WO2009146755A1 Polypeptide |
| 12/10/2009 | WO2009129162A3 Methods and compositions for increasing plant disease resistance and yield |
| 12/10/2009 | WO2009128951A3 Compositions of respiratory synctial virus proteins and methods of use |
| 12/10/2009 | WO2009126896A3 Methods and compositions for root knot nematode control |
| 12/10/2009 | WO2009126688A3 Novel compositions and methods for the treatment of immune related diseases |
| 12/10/2009 | WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor |
| 12/10/2009 | WO2009115509A3 Antigenic protein fragments of streptococcus pneumoniae |
| 12/10/2009 | WO2009112301A3 Polypeptide agents in the form of conjugates of keratin-binding polypeptides, polymers, and effector molecules, method for the production thereof, and use thereof |
| 12/10/2009 | WO2009109860A3 Mutant forms of chlamydia htra |
| 12/10/2009 | WO2009103838A8 Detection and quantification of cyclic imines, based on competitive binding to nicotinic acetylcholine receptors |
| 12/10/2009 | WO2009094172A3 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| 12/10/2009 | WO2009077857A3 Trail variants for treating cancer |
| 12/10/2009 | WO2009058285A3 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
| 12/10/2009 | US20090307802 EPSPS Mutants |
| 12/10/2009 | US20090307795 Zmtcrr-1 plant signal transduction gene and promoter |
| 12/10/2009 | US20090307794 Stress-Induced Transcription Factor Derived from Maize |
| 12/10/2009 | US20090307791 Calcium-activated chloride channel and methods of use thereof |
| 12/10/2009 | US20090307789 Transgenic mollusk and method for producing the same |
| 12/10/2009 | US20090306572 New Polypeptides, uses thereof and methods employing it |
| 12/10/2009 | US20090306350 New purification method of lactoferrin |
| 12/10/2009 | US20090306344 a polypeptide with mutation in at least one specific amino acid capable of potentiating C1-INH protection against complement activity; esterage enzyme inhibitor; gastrointestinal disorders |
| 12/10/2009 | US20090306338 Stabilized GLP-1 Analogs |
| 12/10/2009 | US20090306337 Pegylated, Extended Insulins |
| 12/10/2009 | US20090306195 Fusion Proteins of Mycobacterium Tuberculosis |
| 12/10/2009 | US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
| 12/10/2009 | US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death |
| 12/10/2009 | US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 12/10/2009 | US20090306030 Methods Of Inhibiting Osteoclast Activity |
| 12/10/2009 | US20090305998 Hsp90 inhibitors |
| 12/10/2009 | US20090305992 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305988 Modified peptide of human acidic fibroblast growth factor |
| 12/10/2009 | US20090305986 FGF21 Mutants and uses thereof |
| 12/10/2009 | US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases |
| 12/10/2009 | US20090305984 Engineered CXCL 12 alpha locked dimer polypeptide |
| 12/10/2009 | US20090305982 Muteins of tear lipocalin and methods for obtaining the same |
| 12/10/2009 | US20090305981 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 12/10/2009 | US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 12/10/2009 | US20090305975 Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection |
| 12/10/2009 | US20090305973 Novel peptide and use thereof |
| 12/10/2009 | US20090305972 Novel cancer-associated antigen |
| 12/10/2009 | US20090305971 Nogo-B Receptor |
| 12/10/2009 | US20090305970 Toxin-Like Polypeptides, Polynucleotides Encoding Same and Uses Thereof |
| 12/10/2009 | US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 12/10/2009 | US20090305966 Use of histones for therapeutic purposes |
| 12/10/2009 | US20090305962 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases |
| 12/10/2009 | US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use |
| 12/10/2009 | US20090305952 Anionic polyamide functionalized with a tryptophan unit |
| 12/10/2009 | US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |
| 12/10/2009 | US20090305950 Multimer of extracellular domain of cell surface functional molecule |
| 12/10/2009 | US20090305949 Glycosylated specificity exchanger |
| 12/10/2009 | US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta ) |
| 12/10/2009 | US20090305904 Apoptosis modulator bcl-b and methods for making and using same |
| 12/10/2009 | US20090305434 Method of diagnosing neurophsychiatric diseases, eating disorders or metabolic diseases |
| 12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
| 12/10/2009 | US20090305419 Compositions for linking DNA-binding domains and cleavage domains |
| 12/10/2009 | US20090305400 Modified chaperonin 10 |
| 12/10/2009 | US20090305398 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 12/10/2009 | US20090305352 Activated collagen scaffold materials and their special fused active restoration factors |
| 12/10/2009 | US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/10/2009 | US20090305346 Engineered cleavage half-domains |
| 12/10/2009 | US20090305344 Chimeric alphavirus replicon particles |
| 12/10/2009 | US20090305342 Solubilization and Purification of a Target Protein fused to a Mutant Maltose-Binding Protein |
| 12/10/2009 | US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity |
| 12/10/2009 | US20090305298 Binder for C-Reactive Protein |
| 12/10/2009 | US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases |
| 12/10/2009 | US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES |
| 12/10/2009 | US20090305270 Antigenic surface structure of sperm cells associated with the y chromosome |
| 12/10/2009 | US20090305241 DNA demethylases and uses thereof |
| 12/10/2009 | US20090304901 Modulating plant protein levels |
| 12/10/2009 | US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof |
| 12/10/2009 | US20090304817 Glycosylation Variants of Ricin-Like Proteins |
| 12/10/2009 | US20090304814 Fibrillation resistant proteins |
| 12/10/2009 | US20090304809 Dental fillers, methods, compositions including a caseinate |
| 12/10/2009 | US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 12/10/2009 | US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions |
| 12/10/2009 | US20090304745 Chimeric alphavirus replicon particles |
| 12/10/2009 | US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region |
| 12/10/2009 | US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
| 12/10/2009 | US20090304734 Immunogens for meningitidis-a vaccines |
| 12/10/2009 | US20090304733 Vaccine comprising recombinant ct or lt toxin |
| 12/10/2009 | US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications |
| 12/10/2009 | US20090304731 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae |
| 12/10/2009 | US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof |